Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -48,33% | -27,12% | 687.891,71 | 0,69% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 364.323,09 | 3,28% | 2,71% |
|
NYSE:MRK
Merck
|
128.66 | -8,25% | 5,21% | 325.870,86 | 2,38% | -19,03% |
|
NYSE:PFE
Pfizer
|
28.38 | 9,41% | 39,92% | 160.817,91 | 5,91% | -9,31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
428.59 | 1,69% | 9,74% | 110.599,1 | 0% | 30,14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
984.64 | -29,76% | -23,78% | 106.228,38 | 0% | 13,9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.71 | 59,28% | 69,46% | 90.631,65 | 5,33% | 13,54% |
|
NYSE:ZTS
Zoetis
|
168.87 | 31,02% | 47,24% | 77.054,56 | 1,03% | 11,19% |
|
NYSE:BAX
Baxter International Inc
|
35.24 | 82,83% | 110,41% | 17.957,61 | 3,27% | -3,14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.14 | 5,13% | 15,66% | 13.324,53 | 4,23% | -8,55% |
|
NasdaqGS:UTHR
United Therapeutics
|
269.78 | -10,71% | -1,33% | 11.803,71 | 0% | 5,22% |
|
NYSE:CTLT
Catalent
|
55.52 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
NasdaqGS:CYTK
Cytokinetics
|
59.36 | 0% | 0% | 6.707,63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
38.27 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
155.27 | -9,31% | -0,59% | 5.026,29 | 0,51% | 5,85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
210.98 | 0% | 0% | 4.409,78 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
30.29 | 35,17% | 58,31% | 4.186,4 | 3,58% | -10,73% |
|
NasdaqGS:NEOG
Neogen
|
13.09 | 133,55% | 233,03% | 2.692,43 | 0% | -1,7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
27.66 | -34,78% | -10,92% | 2.552,83 | 0% | 2,03% |
|
LSE:INDV
Indivior PLC
|
14.06 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
